Measles Vaccine
Measles antibodies interfere with immune response in revaccinated adults
Published in Medical Letter on the CDC and FDA, July 6th, 2003
According to published research from Mexico, "The objective of this study was to characterize the kinetics' of the cellular and humoral immune responses elicited by measles vaccine given to previously immune adults."
"The cellular and humoral immune responses to measles were measured in seven healthy adults, before vaccination and at 1, 2, 3, and 4 weeks and 3 months after vaccination, using measles-specific T-cell proliferation and plaque reduction neutralization assays," reported Rosa Maria Wong-Chew and colleagues at the Universidad...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Monkeypox
Smallpox vaccination recommended for those exposed to virus - Vaccine Development
Human vaccine strain of lamb rotavirus (Chinese) NSP4 gene sequenced - African Trypanosomiasis
WHO criteria for trypanosomiasis can be improved by measuring IgM in the CSF - Epilepsy Therapy
Pharmacology of topiramate and lamotrigine compared with phenobarbital - SARS
Death rate lower in countries responding aggressively to initial outbreak - Adverse Drug Effects
Age-related differences found in the side effect profile of citalopram - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
